Sionna Therapeutics Inc.

NASDAQ: SION · Real-Time Price · USD
12.35
-0.22 (-1.75%)
At close: May 09, 2025, 3:59 PM
12.32
-0.24%
After-hours: May 09, 2025, 04:05 PM EDT

Company Description

Sionna Therapeutics, Inc. is a biopharmaceutical company.

The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Sionna Therapeutics Inc.
Sionna Therapeutics Inc. logo
Country United States
IPO Date n/a
Industry Biotechnology
Sector Healthcare
Employees 41
CEO Michael Cloonan M.B.A.

Contact Details

Address:
21 Hickory Drive Suite 500
Waltham, Massachusetts
United States
Website https://www.sionnatx.com/

Stock Details

Ticker Symbol SION
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number US8294011080
Employer ID -
SIC Code n/a

Key Executives

Name Position
Michael Cloonan M.B.A. President, Chief Executive Officer & Director
Elena H. Ridloff C.F.A. Chief Financial Officer & Head of Corporate Development
Jennifer Fitzpatrick J.D. Chief Legal Officer
Vanya Sagar Chief People Officer
Andy Chu Vice President of Information & Technology
Dr. Charlotte McKee M.D. Chief Medical Officer
Dr. Greg Hurlbut Ph.D. Co-Founder & Senior Vice President of Discovery Research
Dr. Mark Munson Ph.D. Co-founder & Senior Vice President of Medicinal Chemistry
Mara Furlow M.S. Senior Vice President of Global Regulatory Affairs & Quality
Meghan Bagshaw Vice President of Programs, Portfolio & Operations

Latest SEC Filings

No SEC filings available.